2170.HK

Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results

Retrieved on: 
星期一, 八月 29, 2022
Technology, Lists of people executed in the United States, Reproductive health, NGS, Solution, Genetic testing, PGT, National Medical Products Administration, Andrology, IVD, Workflow, IVF, Hospital, NMPA, Laboratory, Cryopreservation, Company, Group, III, Industry, Marketing, Medical device, PRC

HONG KONG, Aug 29, 2022 - (ACN Newswire) - Suzhou Basecare Medical Corporation Limited ("Basecare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 2170), an innovative platform of genetic testing solutions for assisted reproduction in China, officially announced the unaudited consolidated interim results for the six months ended June 30, 2022 (the "Reporting Period").

Key Points: 
  • HONG KONG, Aug 29, 2022 - (ACN Newswire) - Suzhou Basecare Medical Corporation Limited ("Basecare Medical" or the "Company", together with its subsidiaries, the "Group", stock code: 2170), an innovative platform of genetic testing solutions for assisted reproduction in China, officially announced the unaudited consolidated interim results for the six months ended June 30, 2022 (the "Reporting Period").
  • Basecare Medical has established a complete series of testing kits in the pipeline of genetic testing kits, which is based on next-generation sequencing (NGS) technology.
  • Meanwhile, the PGT-A kit from Basecare Medical is China's first third-generation IVF genetic testing kit approved by the National Medical Products Administration (NMPA).
  • At present, Basecare Medical has collaborated with over 200 medical institutions across the PRC, including 60 leading reproductive centers.

Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions for Assisted Reproduction

Retrieved on: 
星期四, 七月 14, 2022
Consensus, Technology, Class, Safety, Temperature, Communication, Radio, Refrigeration, IOT, Solution, Hope, Science, Fertility preservation, Company, R, Maintenance, Certification, Cryopreservation, Patient, IVD, Time limit, Genetic testing, IVF, Reproductive health, Consensus decision-making, Ecosystem, Software, Vaccination, Andrology, Medical device

According to the agreement, Basecare Medicaland Haier Biomedical will carry out collaborative R&D in cryogenic refrigeration of the assisted reproduction sector and jointly offer cryopreservation solutions for the assisted reproduction sector, which is another in-depth business collaboration following the capital collaboration between Basecare Medical and Haier Venture Capital FOF.

Key Points: 
  • According to the agreement, Basecare Medicaland Haier Biomedical will carry out collaborative R&D in cryogenic refrigeration of the assisted reproduction sector and jointly offer cryopreservation solutions for the assisted reproduction sector, which is another in-depth business collaboration following the capital collaboration between Basecare Medical and Haier Venture Capital FOF.
  • Dr. LIU Zhanjie, founder and general manager of Haier Biomedical, Mr.LIU Dong, general manager of Haier Venture Capital Qianfeng FOF, and Dr. LIANG Bo, founder of Basecare Medical, attended the signing ceremony.
  • Haier Biomedical, the first company in Qingdao listed on the Science and Technology Innovation Board, was founded to engage in the R&D, manufacturing and sales of biomedical cryopreservation equipment.
  • Basecare Medical is a third-generation IVF clinical solution provider in assisted reproduction in China and the first HKEx-listed IVD company in assisted reproduction.